24
19
1
49
2
2
2c
1b
1d
18
31
3a
1d
2 29
1d
25
John H. Glick, M.D.
78
3a
Professor of Medicine
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
53
4
3
3
3
2
29
4
b
1f
53
Perelman Center for Advanced Medicine
25 3 West Pavilion, Suite 3-300S
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
25 3 West Pavilion, Suite 3-300S
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
2e
Office: 215-662-6065
32 Fax: 215-349-5325
24
95
32 Fax: 215-349-5325
24
Email:
GLICKJH@MAIL.MED.UPENN.EDU
12
GLICKJH@MAIL.MED.UPENN.EDU
13
Education:
21 9 A.B. c
3f Princeton University (Magna Cum Laude), 1965.
21 9 M.D. c
18 Columbia University 38 College of Physicians and Surgeons, 1969.
c
3
3
3
3
8b
Permanent link21 9 A.B. c
3f Princeton University (Magna Cum Laude), 1965.
21 9 M.D. c
18 Columbia University 38 College of Physicians and Surgeons, 1969.
c
2 29
21
1e
1d
24
2b
29
27
23
14e Yuan CM., Stein S., Glick JH., Wasik MA.: Natural killer-like T-cell lymphoma of the small intestine with a distinct immunophenotype and lack of association with gluten-sensitive enteropathy. Archives of Pathology & Laboratory Medicine 127(3): e142-6, Mar 2003.
1cd Schulman KA., Stadtmauer EA., Reed SD., Glick HA., Goldstein LJ., Pines JM., Jackman JA., Suzuki S., Styler MJ., Crilley PA., Klumpp TR., Mangan KF., Glick JH.: Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplantation 31(3): 205-10, Feb 2003.
176 Duggan DB., Petroni GR., Johnson JL., Glick JH., Fisher RI., Connors JM., Canellos GP., Peterson BA.: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.[see comment] Journal of Clinical Oncology 21(4): 607-14, Feb 15 2003.
18c Goldhirsch A., Glick JH., Gelber RD., Coates AS., Senn HJ.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.[see comment]. [Review] [84 refs] Journal of Clinical Oncology 19(18): 3817-27, Sep 15 2001.
1cf Wiernik PH., Leong T., Oken MM., Neiman RS., Habermann TM., Bennett JM., Schuster S., Glick JH.: Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). Leukemia & Lymphoma 40(3-4): 357-63, Jan 2001.
199 Chang JH., Vines E., Bertsch H., Fraker DL., Czerniecki BJ., Rosato EF., Lawton T., Conant EF., Orel SG., Schuchter L., Fox KR., Zieber N., Glick JH., Solin LJ.: The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 91(7): 1231-7, Apr 1 2001.
17c Deming RL., Constine LS., Elman AJ., Hoppe RT., Mauch PM., Dosoretz DE., Pistenmaa DA., Prosnitz LR., Wolkov HB., Yahalom J., Chauvenet A., Connors JM., Glick JH., Leibel S.: Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1269-79, Jun 2000.
195 Prosnitz LR., Connors JM., Deming RL., Yahalom J., Mauch PM., Constine LS., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Wolkov HB., Chauvenet A., Glick JH., Leibel S.: Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1257-68, Jun 2000.
179 Constine LS., Wolkov HB., Yahalom J., Mauch PM., Deming RL., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Prosnitz LR., Chauvenet A., Connors JM., Glick JH., Leibel S.: Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1225-56, Jun 2000.
2c
7
1d
1f
Selected Publications
153 DeMichele A., Putt M., Zhang Y., Glick JH., Norman S.: Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97(9): 2150-9, May 1 2003.14e Yuan CM., Stein S., Glick JH., Wasik MA.: Natural killer-like T-cell lymphoma of the small intestine with a distinct immunophenotype and lack of association with gluten-sensitive enteropathy. Archives of Pathology & Laboratory Medicine 127(3): e142-6, Mar 2003.
1cd Schulman KA., Stadtmauer EA., Reed SD., Glick HA., Goldstein LJ., Pines JM., Jackman JA., Suzuki S., Styler MJ., Crilley PA., Klumpp TR., Mangan KF., Glick JH.: Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplantation 31(3): 205-10, Feb 2003.
176 Duggan DB., Petroni GR., Johnson JL., Glick JH., Fisher RI., Connors JM., Canellos GP., Peterson BA.: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.[see comment] Journal of Clinical Oncology 21(4): 607-14, Feb 15 2003.
18c Goldhirsch A., Glick JH., Gelber RD., Coates AS., Senn HJ.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.[see comment]. [Review] [84 refs] Journal of Clinical Oncology 19(18): 3817-27, Sep 15 2001.
1cf Wiernik PH., Leong T., Oken MM., Neiman RS., Habermann TM., Bennett JM., Schuster S., Glick JH.: Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). Leukemia & Lymphoma 40(3-4): 357-63, Jan 2001.
199 Chang JH., Vines E., Bertsch H., Fraker DL., Czerniecki BJ., Rosato EF., Lawton T., Conant EF., Orel SG., Schuchter L., Fox KR., Zieber N., Glick JH., Solin LJ.: The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 91(7): 1231-7, Apr 1 2001.
17c Deming RL., Constine LS., Elman AJ., Hoppe RT., Mauch PM., Dosoretz DE., Pistenmaa DA., Prosnitz LR., Wolkov HB., Yahalom J., Chauvenet A., Connors JM., Glick JH., Leibel S.: Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1269-79, Jun 2000.
195 Prosnitz LR., Connors JM., Deming RL., Yahalom J., Mauch PM., Constine LS., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Wolkov HB., Chauvenet A., Glick JH., Leibel S.: Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1257-68, Jun 2000.
179 Constine LS., Wolkov HB., Yahalom J., Mauch PM., Deming RL., Dosoretz DE., Elman AJ., Hoppe RT., Pistenmaa DA., Prosnitz LR., Chauvenet A., Connors JM., Glick JH., Leibel S.: Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl: 1225-56, Jun 2000.
2c
44
23
Back to Top
1b
1d
18